Section III
4211 – 4220 of 6388
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappa B inhibitor that impairs osteoclastogenesis
(
- Contribution to journal › Article
-
Mark
Proteoglycans and more--from molecules to biology.
(
- Contribution to journal › Scientific review
-
Mark
Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial
(
- Contribution to journal › Article
-
Mark
Knee extension and flexion muscle power after anterior cruciate ligament reconstruction with patellar tendon graft or hamstring tendons graft: a cross-sectional comparison 3 years post surgery.
(
- Contribution to journal › Article
-
Mark
Giant cell tumor of bone The Scandinavian Sarcoma Group experience
(
- Contribution to journal › Article
-
Mark
Malignant melanoma-Risk factors and the CDKN2A mutation in relation to phenotypes and other cancers.
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Protein C inhibitor--a novel antimicrobial agent.
(
- Contribution to journal › Article
-
Mark
EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISIT
(
- Contribution to journal › Scientific review
-
Mark
Psychometric properties of the French translation of the reduced KOOS and HOOS (KOOS-PS and HOOS-PS)
(
- Contribution to journal › Article
-
Mark
A comparison between biopsy-proven Lupus and ANCA-associated nephritis within a defined geographical area in southern Sweden
(
- Contribution to journal › Published meeting abstract